{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T01:40:01Z","timestamp":1747446001887,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010481","name":"Etablissement Fran\u00e7ais du Sang","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.tracli.2025.01.005","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:22:25Z","timestamp":1736814145000},"page":"164-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Simple method to predict lymphocyte collection for chimeric antigen receptor T-cell engineering"],"prefix":"10.1016","volume":"32","author":[{"given":"O.","family":"Hequet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mialou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cognasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mazet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Chelghoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Candido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vocanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"B\u00e9rard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guironnet-Paquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.H.","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sesques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bachy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ghesquieres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2025.01.005_b0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.tracli.2025.01.005_b0010","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1016\/j.clml.2017.07.030","article-title":"Global registration trial of efficacy and safety of CTL019 in pediatric and young adult patients with Relapsed\/Refractory (R\/R) acute lymphoblastic leukemia (ALL): update to the interim analysis","volume":"17","author":"Buechner","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.tracli.2025.01.005_b0015","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-Cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.tracli.2025.01.005_b0020","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1016\/j.tracli.2025.01.005_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107419","article-title":"Clinical investigations of CAR-T cells for solid tumors: lessons learned and future directions","volume":"205","author":"Bagley","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.tracli.2025.01.005_b0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/vox.12102","article-title":"First comparative evaluation of a new leukapheresis technology in non-cytokine-stimulated donors","volume":"104","author":"Steininger","year":"2014","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2025.01.005_b0035","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1537-2995.2004.03406.x","article-title":"Comparison of two mononuclear cell program settings on two apheresis devices intended to collect high yields of CD14+ and CD3+ cells","volume":"44","author":"Strasser","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.01.005_b0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.transci.2006.10.008","article-title":"Comparison of the Fenwal Amicus and Fresenius Com.tec cell separators for autologous peripheral progenitor cell collection","volume":"36","author":"Altuntas","year":"2007","journal-title":"Transf Aph Sci"},{"key":"10.1016\/j.tracli.2025.01.005_b0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jca.21319","article-title":"Evaluation of the Spectra Optia apheresis system for mononuclear cell (MNC) collection in G-CSF mobilized and nonmobilized healthy donors: results of a multicentre study","volume":"29","author":"Karafin","year":"2014","journal-title":"J Clin Aph"},{"key":"10.1016\/j.tracli.2025.01.005_b0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/vox.13394","article-title":"Evaluation of cell collection efficiency in non-mobilized adult donors for autologous chimeric antigen receptor T-cell manufacturing","volume":"118","author":"Pi\u00f1eyroa","year":"2023","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2025.01.005_b0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1423-0410.2001.00091.x","article-title":"Lymphocyte collection for donor leucocyte infusion from normal donors: estimation of the minimum processed blood volume and safety of the procedure","volume":"81","author":"Sato","year":"2001","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2025.01.005_b0060","first-page":"509","article-title":"The absolute number of circulating CD34+ cells predicts the number of haematopoietic stem cells that can be collected by apheresis","volume":"17","author":"Schots","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tracli.2025.01.005_b0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/14653240410004880","article-title":"Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells","volume":"6","author":"Lane","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1016\/j.tracli.2025.01.005_b0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/039139889902200508","article-title":"Large volume leukapheresis for collecting hemopoietic progenitors: role of CD 34+ precount in predicting successful collection","volume":"22","author":"Menichella","year":"1999","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.tracli.2025.01.005_b0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jca.20062","article-title":"The number of CD34+ cells in peripheral blood as a predictor of the CD34+ yield in patients going to autologous stem cell transplantation","volume":"21","author":"Al","year":"2006","journal-title":"J Clin Aph"},{"key":"10.1016\/j.tracli.2025.01.005_b0080","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1046\/j.1537-2995.2000.40111363.x","article-title":"A kinetic model of CD34+ mobilization and harvest: development of a predictive algorithm for CD34+ cell yield in PBPC collections","volume":"40","author":"Humpe","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.01.005_b0085","first-page":"124","article-title":"Accurate prediction of autologous stem cell yields using a double variable-dependant method assures systematic efficiency of continuous flow collection procedures","volume":"91","author":"Pirelli","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2025.01.005_b0090","doi-asserted-by":"crossref","first-page":"13343","DOI":"10.1111\/trf.15576","article-title":"Validation of simple prediction algorithms to consistently achieve CD3+ and postselection CD34+ targets with leukapheresis","volume":"60","author":"Yoon","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.01.005_b0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.transci.2016.12.015","article-title":"Efficiency of autologous stem cell collection: comparison of three cell separators","volume":"56","author":"Deneys","year":"2017","journal-title":"Transf Aph Sci"},{"key":"10.1016\/j.tracli.2025.01.005_b0100","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/trf.14003","article-title":"Autologous lymphapheresis for the production of chimeric antigen receptor (CAR) T cells","volume":"57","author":"Allen","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.01.005_b0105","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jca.21745","article-title":"Leukocytapheresis in nonmobilized donors for cellular therapy protocols: Evaluation of factors affecting collection efficiency of cells","volume":"34","author":"Cid","year":"2019","journal-title":"J Clin Aph"},{"key":"10.1016\/j.tracli.2025.01.005_b0110","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/trf.15178","article-title":"Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-malignancies","volume":"59","author":"Tuazon","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.01.005_b0115","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/trf.15186","article-title":"Evaluation of peripheral blood mononuclear cell collection by leukapheresis","volume":"59","author":"Chen","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.01.005_b0120","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/cells9051225","article-title":"Current challenges in providing good leukapheresis products for manufacturing of CAR-T cells for patients with relapsed\/refractory NHL or ALL","volume":"9","author":"Korell","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tracli.2025.01.005_b0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0011-2240(85)90005-7","article-title":"Aggregate formation in cryopreserved leukocyte suspensions","volume":"22","author":"Tsvetkov","year":"1985","journal-title":"Cryobiology"},{"key":"10.1016\/j.tracli.2025.01.005_b0130","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1537-2995.2007.01267.x","article-title":"Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product","volume":"47","author":"Calmels","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2025.01.005_b0135","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jcyt.2019.04.004","article-title":"Cryopreservation and thawing of hematopoietic stem cell CD34-induced apoptosis through caspase pathway activation: Key role of granulocytes","volume":"21","author":"Desoutter","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.tracli.2025.01.005_b0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jcyt.2016.04.003","article-title":"Myeloid cells in peripheral mononuclar cell concentrates inhibit the expansion of chimeric antigen","volume":"18","author":"Stroncek","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.tracli.2025.01.005_b0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jca.21485","article-title":"Peripheral blood stem cells collection on spectra optia apheresis system using the continuous mononuclear cell collection protocol: a single center report of 39 procedures","volume":"32","author":"Sanderson","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2025.01.005_b0150","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2016.12.011","article-title":"Lymphocyte circadian clocks control lymph node trafficking and adaptive immune responses","volume":"46","author":"Druzd","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.tracli.2025.01.005_b0155","article-title":"Mathematical modeling reveals kinetic of lymphocyte recirculation in the whole organism","volume":"10","author":"Vitaly","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.tracli.2025.01.005_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01109","article-title":"CAR-T cells hit the tumor microenvironment: strategies to overcome tumor escape","volume":"11","author":"Rodriguez-Garcia","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.tracli.2025.01.005_b0165","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2016.71.3024","article-title":"Lymphoma remissions caused by anti-D19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels","volume":"35","author":"Kochenderfer","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tracli.2025.01.005_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01941","article-title":"Automated manufacture of autologous CD19 CAR-T cells for treatment of non-hodgkin lymphoma","volume":"11","author":"Jackson","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.tracli.2025.01.005_b0175","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/imcb.12254","article-title":"Chimeric antigen receptor T cell persistence and memory cell formation","volume":"97","author":"McLellan","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.tracli.2025.01.005_b0180","first-page":"4898","article-title":"Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma","volume":"4","author":"Locke","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2025.01.005_b0185","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jcyt.2022.05.003","article-title":"leukapheresis guidance and best practices for optimal chimeric antigen T-cell manufacturing","volume":"24","author":"Qayed","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.tracli.2025.01.005_b0190","first-page":"6726","article-title":"Synchronization of the normal human peripheral immune system: a comprehensive circadian systems immunology analysis","volume":"10","author":"Beam","year":"2020","journal-title":"Nature"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782025000059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782025000059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:58:47Z","timestamp":1747443527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782025000059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1246782025000059"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2025.01.005","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simple method to predict lymphocyte collection for chimeric antigen receptor T-cell engineering","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2025.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\ufffdt\ufffd francophone de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}